Dr Clare Whitehead’s grant success

Congratulations to Dr Clare Whitehead who was successful in securing a Mid-Career Researcher Funded Award Grant from the Australian Health Research Alliance (AHRA) Women’s Health Research Translation and Impact Network (WHRTN) and a MDHS Large Equipment Grant

Dr Clare Whitehead was successful in the inaugural Early and Mid-Career Researcher Funded Awards Grant round from the Australian Health Research Alliance (AHRA) Women’s Health Research Translation and Impact Network (WHRTN). This competitive award is designed to advance the career development of women working across the breadth of women’s health research and build capacity in women researchers across underrepresented groups, diverse disciplines and Indigenous research.

Dr Whitehead was also successful in securing a University of Melbourne MDHS Large Equipment Grant which will be used to fund a new Ultrasound machine.

The NHMRC provides funding annually to NHMRC approved Administering Institutions to facilitate the procurement of equipment designed to support high quality health and medical research, as supported by the NHMRC or other competitive grant support.

Dr Clare Whitehead is a NHMRC Neil Hamilton Fairley Research Fellow in the Department of Obstetrics & Gynaecology at The University of Melbourne and a Consultant Maternal Fetal Medicine Subspecialist at the Royal Women's. Her research program focuses on prediction and prevention of adverse pregnancy outcomes, with a focus on imaging and blood based biomarkers.

Clare is passionate about translating benchside findings to the clinic, and ensuring the inclusion of pregnant women in clinical trials, as Chair of the IMPACT Network (the ANZ perinatal clinical trial network), where she is developing a novel adaptive trial to improve outcomes from preterm birth. She is also the lead of the national coronavirus in pregnancy (CHOPAN) registry, Chair of the pregnancy working group for the ASCOT Adaptive trial and Deputy Chair of the Pregnancy Panel for the COVID-19 Evidence Taskforce.